Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Myelomonocytic, Acute

Clinical trial condition

Leukemia, Myelomonocytic, Acute

Explore clinical trials studying Leukemia, Myelomonocytic, Acute. Study availability and eligibility vary by location and protocol.

141 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Acute trial results

Completed

Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00101296

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), +31 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia

NCT00093418

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +29 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

NCT00098826

Conditions: Acute Undifferentiated Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +60 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

NCT00131989

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +37 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00112853

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia

NCT00002925

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: University of California San Diego Cancer Center La Jolla, California, United States

UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States

CCOP - Christiana Care Health Services Wilmington, Delaware, United States

Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

View all 33 locations

View Trial Details

Completed

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

NCT00005793

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00052299

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung Linz, Austria

Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria

AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

View all 55 locations

View Trial Details

Completed

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

NCT00002547

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

NCT00006122

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Innsbruck Universitaetsklinik Innsbruck, Austria

A.Z. St. Jan Bruges, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

CHU Sart-Tilman Liège, Belgium

View all 18 locations

View Trial Details